WallStreetZenWallStreetZen

NASDAQ: CNTA
Centessa Pharmaceuticals PLC Stock

$11.36+0.07 (+0.62%)
Updated Feb 27, 2024
CNTA Price
$11.36
Fair Value Price
$3.47
Market Cap
$1.11B
52 Week Low
$3.03
52 Week High
$11.95
P/E
-6.93x
P/B
4.28x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$157.42M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.46
Operating Cash Flow
-$181M
Beta
0.94
Next Earnings
Mar 28, 2024
Ex-Dividend
N/A
Next Dividend
N/A

CNTA Overview

Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company developing treatments for a range of therapeutic areas including oncology, hematology, immunology/inflammation, neuroscience, hepatology, pulmonology, and nephrology. It focuses on rare diseases with significant unmet need. The company's pipeline includes Lixivaptan), SerpinPC, and Imgatuzumab. Centessa Pharmaceuticals was incorporated in 2020 and is based in Altrincham, U.K.

Zen Score

Industry Average (22)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CNTA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CNTA ($11.36) is overvalued by 227.64% relative to our estimate of its Fair Value price of $3.47 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CNTA ($11.36) is not significantly undervalued (227.64%) relative to our estimate of its Fair Value price of $3.47 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CNTA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CNTA due diligence checks available for Premium users.

Be the first to know about important CNTA news, forecast changes, insider trades & much more!

CNTA News

Valuation

CNTA fair value

Fair Value of CNTA stock based on Discounted Cash Flow (DCF)
Price
$11.36
Fair Value
$3.47
Overvalued by
227.64%
CNTA ($11.36) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CNTA ($11.36) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CNTA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CNTA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-6.93x
Industry
14.95x
Market
36.02x

CNTA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
4.28x
Industry
6.23x
CNTA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CNTA's financial health

Profit margin

Revenue
$0.0
Net Income
-$38.6M
Profit Margin
0%
CNTA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$377.4M
Liabilities
$118.0M
Debt to equity
0.46
CNTA's short-term assets ($332.45M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CNTA's short-term assets ($332.45M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CNTA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$37.4M
Investing
$48.7M
Financing
$14.7M
CNTA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CNTA vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
CNTA$1.11B+0.62%-6.93x4.28x
IMNM$1.11B+4.75%-14.36x182.85x
BCYC$1.11B+2.11%-5.14x3.00x
GERN$1.12B-0.24%-5.90x3.86x
TVGN$1.13B-4.77%-2.30x-12.47x

Centessa Pharmaceuticals Stock FAQ

What is Centessa Pharmaceuticals's quote symbol?

(NASDAQ: CNTA) Centessa Pharmaceuticals trades on the NASDAQ under the ticker symbol CNTA. Centessa Pharmaceuticals stock quotes can also be displayed as NASDAQ: CNTA.

If you're new to stock investing, here's how to buy Centessa Pharmaceuticals stock.

What is the 52 week high and low for Centessa Pharmaceuticals (NASDAQ: CNTA)?

(NASDAQ: CNTA) Centessa Pharmaceuticals's 52-week high was $11.95, and its 52-week low was $3.03. It is currently -4.94% from its 52-week high and 274.92% from its 52-week low.

How much is Centessa Pharmaceuticals stock worth today?

(NASDAQ: CNTA) Centessa Pharmaceuticals currently has 97,629,345 outstanding shares. With Centessa Pharmaceuticals stock trading at $11.36 per share, the total value of Centessa Pharmaceuticals stock (market capitalization) is $1.11B.

Centessa Pharmaceuticals stock was originally listed at a price of $21.75 in May 28, 2021. If you had invested in Centessa Pharmaceuticals stock at $21.75, your return over the last 2 years would have been -47.77%, for an annualized return of -27.73% (not including any dividends or dividend reinvestments).

How much is Centessa Pharmaceuticals's stock price per share?

(NASDAQ: CNTA) Centessa Pharmaceuticals stock price per share is $11.36 today (as of Feb 27, 2024).

What is Centessa Pharmaceuticals's Market Cap?

(NASDAQ: CNTA) Centessa Pharmaceuticals's market cap is $1.11B, as of Feb 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Centessa Pharmaceuticals's market cap is calculated by multiplying CNTA's current stock price of $11.36 by CNTA's total outstanding shares of 97,629,345.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.